Medroxyprogesterone acetate plasma levels after a single oral administration of two drug formulations.
A comparison has been made between the absorption of oral medroxyprogesterone acetate (MPA) in an aqueous suspension preparation and in syrup form. Plasma drug profiles were measured after a single administration of the two formulations in 17 advanced cancer patients. On average the standard form (aqueous suspension) gave peak levels which were lower than the syrup mixture. However, the wide intersubject spread in MPA plasma levels observed in both groups did not allow any statistical significance to be assigned to this difference.
D000284:Administration, Oral; D004304:Dosage Forms; D006801:Humans; D008525:Medroxyprogesterone / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000097:blood; D017258:Medroxyprogesterone Acetate; D013997:Time Factors
D004304:Dosage Forms; D017258:Medroxyprogesterone Acetate; D008525:Medroxyprogesterone